The use and production of synthetic cannabamimetics have increased over the past few years, with products sometimes marketed as herbal mixtures, incense, or potpourri
The medication is designed to work at higher doses for most people
Lets take a closer look at why that matters
To address these limitations, nanotechnology has emerged as a promising solution
We have been waiting for this trial, says Leslie Cho, MD, Co-Section Head of Preventive Cardiology at Cleveland Clinic
In this scenario, patients currently using compounded semaglutide would need to transition to brand-name Ozempic or Wegovy, switch to a different GLP-1 agonist (tirzepatide, liraglutide), or discontinue treatment